Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
08/2003
08/06/2003CN1434923A Conformational and topolodical protein regulation
08/06/2003CN1434921A T2R taste receptors and genes encoding same
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434861A Bacterial isolates of genus kiebsiella, and isomaltulose synthase gene isolated therefrom
08/06/2003CN1434860A Process for producing L-amino acid and novel gene
08/06/2003CN1434832A DNA for encoding the RGI polypeptide
08/06/2003CN1434831A Improvments in or relating to immune responses to HIV
08/06/2003CN1434716A Anti-adhesive agent in relation to pathogenic flora of skin
08/06/2003CN1434679A High temperature cryogenic preservation of biolcally active material
08/06/2003CN1434125A Method for producing single cell protein using residue in extracting steroid sepogenin
08/06/2003CN1434118A Method for separating, idemtifying, purifying, heterotrophying and nitrifying microbe
08/06/2003CN1434117A Method for scale preparing myxobacteria fruiting body using filter paper as only solid medium
08/06/2003CN1434116A Streptomyces ces virdocyaneus sp nov
08/06/2003CN1434115A Streptomycete albogriseus spnov
08/06/2003CN1434114A Chemical method for inducing cordyceps militaris fruiting body entity primodium
08/06/2003CN1434005A Deodorant, deodorizing accelerator and deodorizing method for refuse compost
08/06/2003CN1434004A Biological organic-inorganic compound fertilizer and productive method thereof
08/06/2003CN1434003A Biinoculating micvobial compound bacterium compost method
08/06/2003CN1117160C Process for the preparation of recombinant proteins in E coli by high cell density fermentation
08/06/2003CN1117153C Thermophilic fungal expression system
08/06/2003CN1117151C Riboflavin synthesis in fungi
08/06/2003CN1117150C EB virus DNA sequences encoding diagnostically releavant virus capid antigen expression clones derived through polymerase chain reaction and use of this recombinant antigen in diagnostic
08/06/2003CN1117149C Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/06/2003CN1117144C Production of spore lactic acid bacteria powder
08/05/2003US6603064 Nuclear male sterile plants, method of producing same and methods to restore fertility
08/05/2003US6603063 Isolated polynucleotide that encodes a pesticidally active protein of given amino acid sequence
08/05/2003US6602984 Human elastase IV
08/05/2003US6602712 Recovering mutant bacillus; obtain bacillus, transform with vector containing protein which deactivates hemolysin, recover bacillus with deactivated hemolysin activity, propagate
08/05/2003US6602699 Recombinant DNA fragment comprising the Saccharomyces cerevisiae YNL 279 w gene promoter which, when functionally linked to a structural gene, regulates transcription thereof
08/05/2003US6602687 Culturing bacterial cells transformed with a bacterial expression vector comprising given DNA sequence; may be used in the treatment of neurological disorders, such as Alzheimer's disease, and treating spinal cord damage
08/05/2003US6602684 Culturing a host cell to express a nucleic acid encoding beta (1,4)-N- acetylglucosaminyltransferase III under conditions for production of a polypeptide; can use to provide proteins with improved therapeutic properties
08/05/2003US6602682 Kluyveromyces as a host strain
08/05/2003US6602681 Reacting enzyme, of given amino acid sequence, produced by a recombinant DNA technique from Xenopus laevis
08/05/2003US6602677 Thermostable luciferases and methods of production
08/05/2003US6602667 Of given sequence; useful for diagnosis, prognosis, treatment of inflammatory disorders; screening to identify ligands which bind the polynucleotides
08/05/2003US6602509 Compound and method for the prevention and/or the treatment of allergy
08/05/2003US6602506 Immunogenic composition; bactericidal
08/05/2003US6602503 Complementarity determining regions (CDRs); asthma and inflammatory bowel disease; integrins; antigen binding regions derived from the heavy and/ or light chain variable regions
08/05/2003US6602501 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
07/2003
07/31/2003WO2003062447A2 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
07/31/2003WO2003062430A1 Fermentation of pentose sugars
07/31/2003WO2003062429A1 Novel serine protease
07/31/2003WO2003062428A1 Genetic sequences having methyltransferase activity and uses therefor
07/31/2003WO2003062427A1 Method of screening drug for improving insulin resistance
07/31/2003WO2003062426A1 Novel protein, its dna and use thereof
07/31/2003WO2003062424A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof
07/31/2003WO2003062403A2 Species of fungi and their use in pest and disease control
07/31/2003WO2003062383A2 In vivo gene transfer
07/31/2003WO2003062381A2 Multiply-substituted protease variants
07/31/2003WO2003062380A2 Multiply-substituted protease variants
07/31/2003WO2003062374A2 Synthetic genes for malarial proteins and methods of use
07/31/2003WO2003062370A2 Multimeric proteins and methods of making and using same
07/31/2003WO2003062276A2 Multimers of receptor-binding ligands
07/31/2003WO2003062274A1 Novel proteins and dnas thereof
07/31/2003WO2003062271A1 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof
07/31/2003WO2003062270A2 Fluorescent protein from aequorea coerulscens and uses therof
07/31/2003WO2003062242A1 Biocidal compounds and their preparation
07/31/2003WO2003062173A2 Alanine 2,3- aminomutase
07/31/2003WO2003061674A1 Dietary supplements comprising growth media
07/31/2003WO2003061603A2 Global suppressors of p53 mutations
07/31/2003WO2003061595A2 Antibodies against and compositions containing new amphetamine derivatives
07/31/2003WO2003061580A2 Alteration of rab38 function to modulate mammalian pigmentation
07/31/2003WO2003061365A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
07/31/2003WO2003048308A3 Thermus brockianus nucleic acid polymerases
07/31/2003WO2003035679A3 Molecules
07/31/2003WO2003029484A3 Antimicrobial methods and materials
07/31/2003WO2003025140A3 Transductin-1 and transductin-2 and applications to hereditary deafness
07/31/2003WO2003016333A3 Virus coat protein/receptor chimeras and methods of use
07/31/2003WO2003008603A3 Process for the preparation of l-amino acids using strains of the enterobacteri acea family which contain an attenuated aspa gene
07/31/2003WO2003008602A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an attenuated ugpb gene
07/31/2003WO2003006499A3 Survivin interacting protein tpr1
07/31/2003WO2003004670A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced pts-g expression
07/31/2003WO2003004664A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family with enhanced fba expression
07/31/2003WO2003004607A3 Aggrecanase molecules
07/31/2003WO2002103032A3 Catalases, nucleic acids encoding them and methods for making and using them
07/31/2003WO2002103023A3 Method for producing c9-aldehydes, c9-alcohols by means of divinyl ether synthase
07/31/2003WO2002101005A3 A g-protein coupled receptor and uses therefor
07/31/2003WO2002086123A3 A human g-protein coupled receptor, hgprbmy11, expressed highly in heart and variants thereof
07/31/2003WO2002060936A3 Vaccine and compositions for the prevention and treatment of neisserial infections
07/31/2003WO2002039885A3 Compositions and methods for the therapy and diagnosis of ovarian cancer
07/31/2003WO2002029038A3 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
07/31/2003WO2002024909A3 Receptor nucleic acids and polypeptides
07/31/2003WO2002012286A3 Stress proteins and peptides and methods of use thereof
07/31/2003WO2001096870A3 Immunoassays for anti-hcv antibodies
07/31/2003US20030145352 Nucleic acid molecules from rice and their use for the production of modified starch
07/31/2003US20030145350 Method for increasing the content of fatty acids in plants and micro-organisms
07/31/2003US20030145348 Dehydroquinate dehydrase/shikimate dehydrogenase as a herbicide target
07/31/2003US20030145341 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
07/31/2003US20030144497 Novel human transferase proteins and polynucleotides encoding the same
07/31/2003US20030144495 Drosophila recombination-associated protein and methods for use
07/31/2003US20030144476 Genetic engineered polypeptide; medical diagnosis
07/31/2003US20030144239 Expression system
07/31/2003US20030144232 Expression system
07/31/2003US20030144226 Drug screening for an antiviral agent, viricides; genetic engineering
07/31/2003US20030144209 Bone anabolic agents for the treatment of bone disease
07/31/2003US20030144199 Modified ciliary neurotrophic factor, method of making and methods of use thereof
07/31/2003US20030144192 Crystal proteins which exhibit insecticidal activity against coleopteran insects including red flour beetle larvae (Tribolium castaneum) and Japanese beetle larvae (Popillia japonica)
07/31/2003US20030144187 Comprising an osteoprotegerin polypeptide and an immunoglobulin FC region; treatment of bone disorders
07/31/2003US20030143745 Vector with an origin of replication, a counterselectable marker and a selectable marker that is exciseable by crossover for the unicellular host
07/31/2003US20030143735 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it